New findings suggest semaglutide's benefits may extend well beyond diabetes and weight loss and into airway disease and mood disorders.
News|Articles|April 30, 2024
ICYMI: Drug Topics April 2024 Issue
Author(s)Lauren Massaro
Don’t miss out on the latest pharmacy insights in the Drug Topics April issue.
Advertisement
The Drug Topics April 2024 issue has a lineup of stories that you don't want to miss. Before the month ends, catch up on news and insights about pharmacies' role in expanding reproductive care access, out-of-pocket price caps on inhalers and what they mean for patients, innovations in continuous glucose monitoring technology, and more.
To read these stories and more,
Advertisement
Related to this article
First approved for adults in 2022, the therapy is now cleared for children 12-18 with symptomatic obstructive hypertrophic cardiomyopathy.
With the inherent value medications provide in the greater health care system, Jennifer Hammons, PharmD, DrPH, argues that rural pharmacies deserve the proper recognition.
A claims analysis of 2031 patients aged 10 to 17 years found that nutrition counseling was infrequent and often began months after treatment started.
Community pharmacists offer accessible care, improve medication adherence, and build trust through education, vaccination support, and local health leadership.
Researchers compared vaccine coadministration with single-dose, sequential vaccination for the RSVPreF3 OA vaccine formulation in adults.
A study of women aged 50 to 69 years found that thrombotic risk varied by route of administration, estradiol dose, and duration of use.
Despite technology fostering a new generation of health care delivery, experts believe rural health solutions should be sought elsewhere.
Advertisement
Advertisement
Trending on Drug Topics
1
What Is HIV PrEP and Who Needs It Most?
2
Normal vs. Concerning COVID-19 Vaccine Reactions: A Pharmacist's Guide
3
Validating Fear Before Facts: A Framework for COVID-19 Hesitancy
4
Nearly 1 in 6 Pediatric Patients Have Nutritional Deficiency With GLP-1s
5